Application no. and date | 05769973.8 (espacenet) (Federated) (European Patent Register), 20050802 | Patent/reg. no. and date | DK/EP 1776099, 20091125 | Publication date | 20070425 | Priority no. and date | US 598700 P, 20040803 | EP pub. no. and date |
EP 1776099 20070425 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | 137292 | Inventor | GROSS, Gerhard, Markus Pflüger Strasse 6
79539 Lörrach, DE, OTTINGER, Isabel, Wackerstrasse 11a
79108 Freiburg, DE, CAMENISCH, Gian, P., Haselrain 73
CH-4125 Riehen, CH, WASMUTH, Daniel, Rebenstrasse 18
CH-4112 Bättwil-Flüh, CH | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/165 (2006.01) , A61K 38/13 (2006.01) , A61P 9/00 (2006.01) , A61P 9/12 (2006.01) | Title | Fremgangsmåder til forbedring af biotilgængeligheden af en renininhibitor | Int. application no. | EP2005008369 | Int. publication no. | WO2006013094 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|